These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 35086254)

  • 21. Outcomes of transcutaneous retrobulbar Amphotericin B (TRAMB) as an adjuvant therapy for rhino-orbital-cerebral mucormycosis (ROCM) following COVID-19.
    Shakrawal J; Sharma V; Goyal A; Kumar D; Meena S; Tiwari S; Jain V; Elhence P; Soni K; Choudhury B; Bhatnagar K; Garg MK; Misra S
    Int Ophthalmol; 2023 Jun; 43(6):1919-1926. PubMed ID: 36427099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rhino-Orbito-Cerebral-Mucormycosis During the COVID-19 Second Wave in 2021 - A Preliminary Report from a Single Hospital.
    Arora R; Goel R; Khanam S; Kumar S; Shah S; Singh S; Chhabra M; Meher R; Khurana N; Sagar T; Kumar S; Garg S; Kumar J; Saxena S; Pant R
    Clin Ophthalmol; 2021; 15():3505-3514. PubMed ID: 34429582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CT and MRI Findings of Invasive Mucormycosis in the Setting of COVID-19: Experience From a Single Center in India.
    Joshi AR; Muthe MM; Patankar SH; Athawale A; Achhapalia Y
    AJR Am J Roentgenol; 2021 Dec; 217(6):1431-1432. PubMed ID: 34161127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spectrum of intracranial complications of rhino-orbito-cerebral mucormycosis - resurgence in the era of COVID-19 pandemic: a pictorial essay.
    Kaushik KS; Ananthasivan R; Acharya UV; Rawat S; Patil UD; Shankar B; Jose A
    Emerg Radiol; 2021 Dec; 28(6):1097-1106. PubMed ID: 34605991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study of rhino-orbital-cerebral mucormycosis and its correlates during COVID-19 pandemic in a tertiary eye care institute of central India.
    Verma V; Sarkar D; Moharana B; Singh P; Noyadu R; Sharma B
    Indian J Ophthalmol; 2023 Dec; 71(12):3669-3676. PubMed ID: 37991302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imaging Spectrum of Coronavirus Disease- 2019 Associated Rhino-Orbital-Cerebral Mucormycosis; From Sinonasal Inflammation to Intracranial Involvement.
    Khademi B; Dehghan A; Zia Z; Dehghan Y
    Acad Radiol; 2023 Sep; 30(9):1904-1914. PubMed ID: 36581530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A clinico-pathological study of COVID-19 associated rhino-orbital-cerebral mucormycosis.
    Mani S; Thirunavukkarasu A
    Indian J Ophthalmol; 2022 Mar; 70(3):1013-1018. PubMed ID: 35225563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surgical & medical management of ROCM (Rhino-orbito-cerebral mucormycosis) epidemic in COVID-19 era and its outcomes - a tertiary care center experience.
    Soni K; Das A; Sharma V; Goyal A; Choudhury B; Chugh A; Kumar D; Yadav T; Jain V; Agarwal A; Garg M; Bhatnagar K; Elhence P; Bhatia PK; Garg MK; Misra S
    J Mycol Med; 2022 May; 32(2):101238. PubMed ID: 34979299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicoradiological Profile of COVID-19-Associated Rhino-Orbital Cerebral Mucormycosis with a Focus on Computed Tomography: A Clinical Case Series and Review.
    Prabhakar A; Bansal S; Vyas S; Bhatia V; Kumar A; Patro S; Singh U; Panda N; Singh P; Bhalla A; Puri GD; Ahuja CK
    Am J Trop Med Hyg; 2023 Sep; 109(3):600-607. PubMed ID: 37487562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Magnetic resonance imaging in rhino-orbital-cerebral mucormycosis.
    Sreshta K; Dave TV; Varma DR; Nair AG; Bothra N; Naik MN; Sistla SK
    Indian J Ophthalmol; 2021 Jul; 69(7):1915-1927. PubMed ID: 34146057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Presentation and outcome of rhino-orbital-cerebral mucormycosis in patients with diabetes.
    Bhansali A; Bhadada S; Sharma A; Suresh V; Gupta A; Singh P; Chakarbarti A; Dash RJ
    Postgrad Med J; 2004 Nov; 80(949):670-4. PubMed ID: 15537854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A cross-sectional study to describe the spectrum of ocular manifestations and risk factors of mucormycosis presenting to a tertiary hospital of East India.
    Raj A; Nishant P; Sadhukhan K; Saha BC; Sinha U; Kokkayil P; Gupta A; Kumar A; Tiwari P
    Indian J Ophthalmol; 2023 Jan; 71(1):249-256. PubMed ID: 36588245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicoradiological profile and outcome of cavernous sinus syndrome with coronavirus disease-2019-associated rhino-orbito-cerebral mucormycosis.
    Sulena S; Dhawan M; Singh N; Arora H; Singh G; Aggarwal V; Tapasvi C
    J Neurosci Rural Pract; 2022; 13(4):730-739. PubMed ID: 36743739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cross-sectional study to describe the severity, bio-chemical associations, and final outcomes of COVID-19-associated rhino-orbital-cerebral mucormycosis in a tertiary hospital of East India.
    Kumari A; Ranjan A; Nishant P; Sinha S; Sinha RK
    Indian J Ophthalmol; 2023 May; 71(5):2193-2198. PubMed ID: 37202947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COVID-19 associated Rhino-Orbito-Cerebral Mucormycosis: Imaging spectrum and Clinico-radiological correlation- a single Centre experience.
    Patel DD; Adke S; Badhe PV; Lamture S; Marfatia H; Mhatre P
    Clin Imaging; 2022 Feb; 82():172-178. PubMed ID: 34864270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rhino-orbital mucormycosis: Our experiences with clinical features and management in a tertiary care center.
    Singh SP; Rana J; Singh VK; Singh R; Sachan R; Singh S; Jain S
    Rom J Ophthalmol; 2021; 65(4):339-353. PubMed ID: 35087975
    [No Abstract]   [Full Text] [Related]  

  • 37. Rhino-orbital mucormycosis following COVID-19 in previously non-diabetic, immunocompetent patients.
    Nair AG; Adulkar NG; D'Cunha L; Rao PR; Bradoo RA; Bapaye MM; Kothari A; Dave TV; Shinde CA
    Orbit; 2021 Dec; 40(6):499-504. PubMed ID: 34338124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinico-Radiological-Pathological Correlation of Visual Loss in COVID-Associated Rhino-Orbito-Cerebral Mucormycosis.
    Goel R; Arora R; Shah S; Chhabra M; Kumar J; Khurana N; Gupta S; Khanam S; Kumar S; Singh S; Meher R; Thakar M; Garg A
    Ophthalmic Plast Reconstr Surg; 2022 May-Jun 01; 38(3):242-249. PubMed ID: 34919070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. To determine the role of transcutaneous retrobulbar amphotericin B in COVID-19-related rhino-orbital-cerebral mucormycosis.
    Kaur R; Sehgal A; Gupta P; Budhiraja G; Sharma V; Aggarwal A
    Oman J Ophthalmol; 2024; 17(2):198-204. PubMed ID: 39132108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. "MuCovid-21" study: Mucormycosis at an Indian tertiary care centre during the COVID-19 pandemic.
    Kumar S; Choudhary R; Pandey VP
    J R Coll Physicians Edinb; 2021 Dec; 51(4):352-358. PubMed ID: 34882132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.